OPIR Says Surplus of Drug Imports “Unrelated to International Competitiveness of Domestic Industry”

In a report on the surplus of drug imports and the domestic pharmaceutical industry, which was recently compiled by the Office of Pharmaceutical Industry Research (OPIR) at the Japan Pharmaceutical Manufacturers Association (JPMA), the OPIR expressed that there is no...read more